Victor Seitles
Director of Finance/CFO at Quogue Capital LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wayne P. Rothbaum | M | 56 |
Quogue Capital LLC
 Quogue Capital LLC Investment ManagersFinance Quogue Capital LLC (Quogue Capital) is a private equity firm founded in 2002 by Wayne P. Rothbaum. The firm is headquartered in New York.
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 22 years |
| Joseph Scaminace | M | 71 | 14 years | |
| Ronald Tysoe | M | 71 | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James J. Johnson | M | 77 | 11 years | |
| Paul R. Carter | M | 84 | 7 years | |
| Jeffrey Leventhal | M | - |
Binghamton University School of Management
| 2 years |
| Maria Fardis | M | 56 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 1 years |
| David Johnson | M | 59 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 3 years |
| Jane Huang | M | 51 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 1 years |
| Flavia Borellini | M | 65 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | 3 years |
| Benjamin R. Sommerness | M | 53 | 1 years | |
| Charlie Fraas | M | - |
Binghamton University School of Management
| 4 years |
| Van Scoy Russ L Francis | M | - |
Binghamton University School of Management
| 4 years |
| Linda Due | F | - |
Binghamton University School of Management
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 42.86% |
| Netherlands | 5 | 35.71% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Victor Seitles
- Personal Network